Evidence map›Paper›PMID 42395828›Full record

ReviewRSC advances2026

Research progress on immobilized penicillin G acylase and industrial applications.

Pen Jin, Hongyi Tu, Nan Wang, Fengying Li, Xiaodong Wei, Zhenbin Chen

Abstract readReview
In one paragraph

Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pen JinCollege of Materials Science and Engineering, Lanzhou University of Technology Lanzhou 730050 China zhenbinchen@163.com.
Hongyi TuCollege of Materials Science and Engineering, Lanzhou University of Technology Lanzhou 730050 China zhenbinchen@163.com.
Nan WangCollege of Materials Science and Engineering, Lanzhou University of Technology Lanzhou 730050 China zhenbinchen@163.com.
Fengying LiSchool of Chemical Engineering, Northwest Minzu University Lanzhou 730030 China.
Xiaodong WeiSchool of Chemical Engineering, Northwest Minzu University Lanzhou 730030 China.
Zhenbin ChenCollege of Materials Science and Engineering, Lanzhou University of Technology Lanzhou 730050 China zhenbinchen@163.com.ORCID https://orcid.org/0000-0003-1291-6078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immobilized penicillin G acylase (PGA) is a critical industrial biocatalyst for converting penicillin G into 6-aminopenicillanic acid (6-APA), a key intermediate in the synthesis of β-lactam antibiotics. Although various microorganisms can produce penicillin acylases, free PGA is highly susceptible to structural instability and environmental factors such as temperature and pH fluctuations, leading to a significant activity loss. Furthermore, the separation of free enzymes from reaction systems remains technically challenging, increasing operational complexity and cost. To overcome these limitations, immobilization strategies have been extensively explored. Immobilized PGA exhibits superior stability, reusability, and operational robustness, which are highly desirable for industrial applications. These advantages also lead to improved product purity, reduced contamination risks, and economic benefits. However, immobilization does not necessarily improve intrinsic catalytic efficiency, instead, it often involves a trade-off between catalytic activity and stability due to conformational constraints and mass transfer limitations. Although improved catalytic performance is sometimes reported, such enhancement generally reflects apparent activity rather than intrinsic catalytic efficiency. This review systematically summarizes the origins, classification, structure, and catalytic mechanisms of PGA. It also critically evaluates recent progress in immobilization methods, carrier materials, reaction media, enzyme activity regeneration, and reactor design, providing insights into future challenges and opportunities in this field.

Identifiers

PMID42395828
PMCPMC13326579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.